Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Food Funct ; 14(7): 3107-3125, 2023 Apr 03.
Article in English | MEDLINE | ID: mdl-36942614

ABSTRACT

Opuntia ficus-indica (L.) Miller (OFI), belonging to the family Cactaceae, is widely cultivated not only for its delicious fruits but also for its health-promoting effects, which enhance the role of OFI as a potential functional food. In this study, the in vitro collagenase and elastase enzyme inhibitory effects of extracts from different parts of OFI were evaluated. The most promising extracts were formulated as creams at two concentrations (3 and 5%) to investigate their effects on a D-galactose (D-gal)-induced skin-aging mouse model. The ethanolic extracts of the peel and cladodes exhibited the highest enzyme inhibitory effects. Cream made from the extract of OFI peel (OP) (5%) and cream from OFI cladodes extract (OC) (5%) significantly decreased the macroscopic aging of skin scores. Only a higher concentration (5%) of OC showed the normalization of superoxide dismutase (SOD) and malondialdehyde (MDA) skin levels and achieved significant improvements as compared to the vitamin E group. Both OC and OP (5%) showed complete restoration of the normal skin structure and nearly normal collagen fibres upon histopathological examination. The Ultra-Performance Liquid Chromatography High Resolution Mass Spectrometry (UHPLC-ESI-TOF-MS) metabolite profiles revealed the presence of organic acids, phenolic acids, flavonoids, betalains, and fatty acids. Flavonoids were the predominant phytochemical class (23 and 22 compounds), followed by phenolic acids (14 and 17 compounds) in the ethanolic extracts from the peel and cladodes, respectively. The anti-skin-aging effects could be attributed to the synergism of different phytochemicals in both extracts. From these findings, the OFI peel and cladodes as agro-waste products are good candidates for anti-skin-aging phytocosmetics.


Subject(s)
Opuntia , Plant Extracts , Skin Aging , Skin Cream , Opuntia/chemistry , Skin Aging/drug effects , Plant Extracts/chemistry , Plant Extracts/pharmacology , Animals , Mice , Models, Animal , Skin Cream/chemistry , Skin Cream/pharmacology , Skin/drug effects , Skin/metabolism , Superoxide Dismutase/metabolism , Malondialdehyde/metabolism , Liquid Chromatography-Mass Spectrometry
2.
Molecules ; 28(2)2023 Jan 16.
Article in English | MEDLINE | ID: mdl-36677961

ABSTRACT

The presence of phenobarbital and formaldehyde in drugs, food, and beverages can lead to various health issues, including inflammation, oncogenesis, and neurological distress. Psychological stress leads to mood fluctuations and the onset of skin inflammation. Skin inflammation has a range of causes, including chemicals, heavy metals, infection, immune-related disorders, genetics, and stress. The various treatments for skin inflammation include medical and cosmetic creams, diet changes, and herbal therapy. In this study, we investigated the effects of Avocom-M and pomegranate seed oil extract (PSOE) against phenobarbital- and formaldehyde-induced skin biochemical changes in rats. We analyzed the constituents of PSOE using gas chromatography-mass spectrometry and inductively coupled plasma-mass spectrometry. We also observed biochemical changes in the skin of human volunteers with and without TROSYD and PSOE as a skin cream. We compared the biochemical changes in human volunteers' skin before treatment and 21 days after the treatment stopped. The outcomes showed an improvement in the rats' biochemical status, due to PSOE and Avocom-M treatment. The human volunteers treated with TROSYD and PSOE showed substantial amelioration of skin inflammation. PSOE, Avocom-M, and TROSYD produced beneficial effects by reducing the levels of cyclooxygenase-2, lipid peroxidation, tyrosinase, hyaluronidase, elastase, collagenase, and nitric oxide in the animals tested on and in human volunteers.


Subject(s)
Dermatitis , Pomegranate , Humans , Animals , Rats , Pilot Projects , Skin Cream/pharmacology , Plant Extracts/pharmacology , Plant Extracts/chemistry , Plant Oils/pharmacology , Plant Oils/chemistry , Inflammation/drug therapy , Formaldehyde
3.
Sci Rep ; 12(1): 2180, 2022 02 09.
Article in English | MEDLINE | ID: mdl-35140283

ABSTRACT

Mosquito-borne infections like dengue, malaria, chikungunya, etc. are a nuisance and can cause profound discomfort to people. Due to the objectional side effects and toxicity associated with synthetic pyrethroids, N,N-diethyl-3-methylbenzamide (DEET), N,N-diethyl phenylacetamide (DEPA), and N,N-di ethyl benzamide (DEBA) based mosquito repellent products, we developed an essential oil (EO) based mosquito repellent cream (EO-MRC) using clove, citronella and lemongrass oil. Subsequently, a formulation characterization, bio-efficacy, and safety study of EO-MRC were carried out. Expression of Anti-OBP2A and TRPV1 proteins on mosquito head parts were studied by western blotting. In-silico screening was also conducted for the specific proteins. An FT-IR study confirmed the chemical compatibility of the EOs and excipients used in EO-MRC. The thermal behaviour of the best EOs and their mixture was characterized by thermogravimetric analysis (TGA). GC-MS examination revealed various chemical components present in EOs. Efficacy of EO-MRC was correlated with 12% N,N-diethyl benzamide (DEBA) based marketed cream (DBMC). Complete protection time (CPT) of EO-MRC was determined as 228 min. Cytotoxicity study on L-132 cell line confirmed the non-toxic nature of EO-MRC upon inhalation. Acute dermal irritation study, acute dermal dose toxicity study, and acute eye irritation study revealed the non-toxic nature of EO-MRC. Non-target toxicity study on Danio rerio confirmed EO-MRC as safer for aquatic non-target animals. A decrease in the concentration of acetylcholinesterase (AChE) was observed in transfluthrin (TNSF) exposed Wistar rats. While EO-MRC did not alter the AChE concentrations in the exposed animals. Results from western blotting confirmed that Anti-OBP2A and TRPV1 proteins were inhibited in TNSF exposed mosquitoes. Mosquitoes exposed to EO-MRC showed a similar expression pattern for Anti-OBP2A and TRPV1 as the control group. In silico study revealed eight identified compounds of the EOs play significant roles in the overall repellency property of the developed product. The study emphasizes the mosquito repellent activity of EO-MRC, which could be an effective, eco-friendly, and safer alternative to the existing synthetic repellents for personal protection against mosquitoes during field conditions.


Subject(s)
Insect Repellents/chemistry , Insect Repellents/pharmacology , Oils, Volatile/chemistry , Oils, Volatile/pharmacology , Skin Cream/chemistry , Skin Cream/pharmacology , Acetylcholinesterase/metabolism , Animals , Cell Survival/drug effects , Cells, Cultured , Culicidae , Cymbopogon/chemistry , Drug Compounding , Eye/drug effects , Female , Humans , Insect Repellents/adverse effects , Male , Molecular Docking Simulation , Oils, Volatile/adverse effects , Plant Oils/chemistry , Rabbits , Rats, Wistar , Skin/drug effects , Skin Cream/adverse effects , Skin Irritancy Tests , Syzygium/chemistry , Terpenes/chemistry , Zebrafish
4.
Biomed Res Int ; 2021: 6474706, 2021.
Article in English | MEDLINE | ID: mdl-34692837

ABSTRACT

Despite advances in diabetes care, impaired diabetic wound healing remains a significant clinical problem. The present study was aimed at developing a novel cream based on Ginkgo biloba extract and investigating its wound healing effect on full-thickness wounds in diabetic rats. The topical formulated oil-in-water emulsion-based cream contains Ginkgo biloba aqueous extract in an amount of about 1% to 5% as an active agent. The prepared formula was subjected to physicochemical assessment and pharmacotechnical characterization. Eighteen alloxan-induced diabetic rats completing full-thickness excisional skin wounds were randomly divided into three groups topically treated with either a normal saline (control group), the reference drug ("Cytol Centella cream®"), and cream based on the Ginkgo biloba extract. The response to treatment was assessed by macroscopic, qualitative, and quantitative histopathological analysis. The prepared formula showed good physicochemical properties. The rheological behavior of the prepared cream followed a non-Newtonian pseudoplastic pattern at different storage temperatures. The cream, which is a macroemulsion with uniform size distribution, remained stable for 6 months. Skin tolerance studies confirmed the compatibility of the cream with the skin. During the experimental trial, the cream based on the Ginkgo biloba-treated group showed significant improvements over the control and reference groups for both general wound appearance and healing dynamics. This increased rate of closure of wounds in diabetic rats was associated with increased collagen synthesis. Our findings showed that the cream could be a promising and innovative topical treatment with Ginkgo biloba extract for the management of acute diabetic wounds.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Ginkgo biloba/chemistry , Plant Extracts/pharmacology , Skin Cream/pharmacology , Skin/drug effects , Wound Healing/drug effects , Administration, Topical , Animals , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/pathology , Disease Models, Animal , Male , Rats , Rats, Wistar , Skin/pathology
5.
Biomed Res Int ; 2021: 4593759, 2021.
Article in English | MEDLINE | ID: mdl-34552986

ABSTRACT

The present study deals with the evaluation of the age-defying potential of topical cream formulations bearing Geranium essential oil/Calendula essential oil-entrapped ethanolic lipid vesicles (ELVs). Two types of cream formulations were prepared, viz., conventional and ELVs spiked o/w creams. Essential oil- (EO-) loaded ELVs were characterized by vesicle size, polydispersity index, encapsulation efficiency, and scanning electron microscopy. The cream formulations were evaluated for homogeneity, spreadability, viscosity, pH, in vitro antioxidant capacity, sun protection factor, and in vitro collagenase and elastase inhibition capacity. Confocal laser scanning microscopy (CLSM) was performed to ascertain skin permeation of conventional and vesicular cream. The results of in vitro antioxidant studies showed that GEO-/CEO-loaded vesicular creams have notable antioxidant capacity when compared to nonvesicular creams. GEO- or CEO-loaded vesicular creams exhibited the highest SPF value 10.26 and 18.54, respectively. Both the EO-based vesicular creams showed in vitro collagenase and elastase enzyme inhibition capacity. CLSM images clearly depicted that vesicular cream deep into the skin layers. From the research findings, the age-defying potential and photoprotective effects of GEO and CEO were confirmed. It can be concluded that ELVs are able to preserve the efficiency of EOs and have the potential to combat skin aging.


Subject(s)
Calendula/chemistry , Drug Delivery Systems , Geranium/chemistry , Lipids/chemistry , Oils, Volatile/administration & dosage , Oils, Volatile/pharmacology , Skin Aging/drug effects , Skin Cream/pharmacology , Administration, Cutaneous , Animals , Antioxidants/pharmacology , Biphenyl Compounds/chemistry , Collagenases/metabolism , Drug Compounding , Enzyme Inhibitors/pharmacology , Ethanol/chemistry , Female , Free Radical Scavengers/pharmacology , Hydrogen-Ion Concentration , Male , Nitric Oxide/metabolism , Pancreatic Elastase/antagonists & inhibitors , Pancreatic Elastase/metabolism , Particle Size , Picrates/chemistry , Rats , Skin Irritancy Tests , Sunscreening Agents/pharmacology , Viscosity
6.
Int J Med Sci ; 18(14): 3299-3308, 2021.
Article in English | MEDLINE | ID: mdl-34400899

ABSTRACT

Plant tissue culture holds immense potential for the production of secondary metabolites with various physiological functions. We recently established a plant tissue culture system capable of producing secondary metabolites from Aster yomena. This study aimed to uncover the mechanisms underlying the potential therapeutic effects of Aster yomena callus pellet extract (AYC-P-E) on photoaging-induced skin pigmentation. Excessive melanogenesis was induced in B16F10 melanoma cells using α-melanocyte stimulating hormone (α-MSH). The effects of AYC-P-E treatment on melanin biosynthesis inducers and melanin synthesis inhibition were assessed. Based on the results, a clinical study was conducted in subjects with skin pigmentation. AYC-P-E inhibited melanogenesis in α-MSH-treated B16F10 cells, accompanied by decreased mRNA and protein expression of melanin biosynthesis inducers, including cyclic AMP response element-binding protein (CREB), tyrosinase, microphthalmia-associated transcription factor (MITF), tyrosinase related protein-1 (TRP-1), and TRP-2. This anti-melanogenic effect was mediated by mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) and protein kinase B (AKT) phosphorylation. Treatment of subjects with skin pigmentation with AYC-P-E-containing cream formulations resulted in 3.33%, 7.06%, and 8.68% improvement in the melanin levels at 2, 4, and 8 weeks, respectively. Our findings suggest that AYC-P-E inhibits excessive melanogenesis by activating MEK/ERK and AKT signaling, potentiating its cosmetic applications in hyperpigmentation treatment.


Subject(s)
Aster Plant/chemistry , Facial Dermatoses/drug therapy , Hyperpigmentation/drug therapy , Melanins/antagonists & inhibitors , Plant Extracts/pharmacology , Adult , Animals , Cell Line, Tumor , Female , Humans , Hyperpigmentation/etiology , Hyperpigmentation/physiopathology , MAP Kinase Signaling System/drug effects , Melanins/biosynthesis , Mice , Middle Aged , Plant Extracts/therapeutic use , Skin Aging/physiology , Skin Cream/pharmacology , Skin Cream/therapeutic use , Skin Pigmentation/drug effects , Skin Pigmentation/radiation effects , Treatment Outcome
7.
Molecules ; 26(9)2021 May 10.
Article in English | MEDLINE | ID: mdl-34068613

ABSTRACT

Nowadays, natural dyes are expected by the cosmetic and food industries. In contrast to synthetic dyes, colorants derived from natural sources are more environmentally friendly and safer for human health. In this work, plant extracts from Gomphrena globasa L., Clitoria ternatea L., Carthamus tinctorius L., Punica granatum L. and Papaver rhoeas L. as the natural and functional dyes for the cosmetics industry were assessed. Cytotoxicity on keratinocyte and fibroblast cell lines was determined as well as antioxidant and anti-aging properties by determining their ability to inhibit the activity of collagenase and elastase enzymes. In addition, the composition of the extracts was determined. The obtained extracts were also applied in face cream formulation and color analyses were performed. It has been shown that the obtained extracts were characterized by no cytotoxicity and a high antioxidant potential. The extracts also show strong ability to inhibit the activity of collagenase and moderate ability to inhibit elastase and provide effective and long-lasting hydration after their application on the skin. Application analyses showed that the extracts of P. rhoeas L., C. ternatea L. and C. tinctorius L. can be used as effective cosmetic dyes that allow for attainment of an intense and stable color during the storage of the product. The extracts of P. granatum L. and G. globasa L., despite their beneficial effects as active ingredients, did not work effectively as cosmetic dyes, because cosmetic emulsions with these extracts did not differ significantly in color from emulsions without the extract.


Subject(s)
Antioxidants/pharmacology , Coloring Agents/pharmacology , Cosmetics/pharmacology , Cytoprotection , Desiccation , Flowers/chemistry , Plant Extracts/pharmacology , Benzothiazoles/chemistry , Biphenyl Compounds/chemistry , Cell Death/drug effects , Collagenases/metabolism , Color , Cytoprotection/drug effects , HaCaT Cells , Humans , Kinetics , Matrix Metalloproteinase Inhibitors/pharmacology , Oxazines/metabolism , Pancreatic Elastase/antagonists & inhibitors , Pancreatic Elastase/metabolism , Picrates/chemistry , Plants/chemistry , Skin Cream/pharmacology , Sulfonic Acids/chemistry , Ultraviolet Rays , Water Loss, Insensible/drug effects , Xanthenes/metabolism
8.
J Drugs Dermatol ; 20(2): 134-142, 2021 02 01.
Article in English | MEDLINE | ID: mdl-33538559

ABSTRACT

BACKGROUND: Impetigo, a highly contagious bacterial skin infection commonly occurring in young children, but adults may also be affected. The superficial skin infection is mainly caused by Staphylococcus aureus (S. aureus) and less frequently by Streptococcus pyogenes (S. pyogenes). Antimicrobial resistance has become a worldwide concern and needs to be addressed when selecting treatment for impetigo patients. An evidence-based impetigo treatment algorithm was developed to address the treatment of impetigo for pediatric and adult populations. METHODS: An international panel of pediatric dermatologists, dermatologists, pediatricians, and pediatric infectious disease specialists employed a modified Delphi technique to develop the impetigo treatment algorithm. Treatment recommendations were evidence-based, taking into account antimicrobial stewardship and the increasing resistance to oral and topical antibiotics. RESULTS: The algorithm includes education and prevention of impetigo, diagnosis and classification, treatment measures, and follow-up and distinguishes between localized and widespread or epidemic outbreaks of impetigo. The panel adopted the definition of localized impetigo of fewer than ten lesions and smaller than 36 cm2 area affected in patients of two months and up with no compromised immune status. Resistance to oral and topical antibiotics prescribed for the treatment of impetigo such as mupirocin, retapamulin, fusidic acid, have been widely reported. CONCLUSIONS: When prescribing antibiotics, it is essential to know the local trends in antibiotic resistance. Ozenoxacin cream 1% is highly effective against S. pyogenes and S. aureus, including methycyllin-susceptible and resistant strains (MRSA), and may be a suitable option for localized impetigo.J Drugs Dermatol. 2021;20(2):134-142. doi:10.36849/JDD.5475 THIS ARTICLE HAD BEEN MADE AVAILABLE FREE OF CHARGE. PLEASE SCROLL DOWN TO ACCESS THE FULL TEXT OF THIS ARTICLE WITHOUT LOGGING IN. NO PURCHASE NECESSARY. PLEASE CONTACT THE PUBLISHER WITH ANY QUESTIONS.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Critical Pathways/standards , Impetigo/drug therapy , Staphylococcus aureus/drug effects , Streptococcus pyogenes/drug effects , Aminopyridines/pharmacology , Aminopyridines/therapeutic use , Anti-Bacterial Agents/pharmacology , Antimicrobial Stewardship/standards , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Bridged Bicyclo Compounds, Heterocyclic/therapeutic use , Delphi Technique , Diterpenes/pharmacology , Diterpenes/therapeutic use , Drug Resistance, Bacterial , Evidence-Based Medicine/standards , Fusidic Acid/pharmacology , Fusidic Acid/therapeutic use , Humans , Impetigo/diagnosis , Impetigo/microbiology , Microbial Sensitivity Tests/standards , Mupirocin/pharmacology , Mupirocin/therapeutic use , Practice Guidelines as Topic , Quinolones/pharmacology , Quinolones/therapeutic use , Skin Cream/pharmacology , Skin Cream/therapeutic use , Staphylococcus aureus/isolation & purification , Streptococcus pyogenes/isolation & purification , Systematic Reviews as Topic
9.
Arch Microbiol ; 203(4): 1707-1715, 2021 May.
Article in English | MEDLINE | ID: mdl-33459816

ABSTRACT

Staphylococcus aureus (S.aureus) is both a colonizer as well as a human pathogen that causes a variety of diseases. Mupirocin is a topical antimicrobial agent which is very effective against S.aureus infection. However, treating the S.aureus infection using mupirocin could be complicated due to biofilm formation. Consequently, resistance to mupirocin occurs and leads to chronic infection. The combination of mupirocin with a compound that has biofilm eradicating effect would be an ideal solution for effectively treating biofilm infections. Therefore, in this study, we have investigated the biofilm inhibitory and eradication effect of mupirocin with three essential oils (Cinnamon Oil (CO), Eugenol (EU) and Eucalyptus Oil (EO)) against sessile S.aureus. From these preliminary results, it was found that the mupirocin-CO (0.2 µg/ml-5.218 mg/ml) combination has a better synergistic antibiofilm effect against sessile S.aureus and the fractional inhibitory concentration index was found to be 0.458. The best combination of mupirocin with CO was loaded into a non-greasy O/W cream. The physico-chemical and microbiological evaluations were carried out for the prepared cream. The prepared cream has better biofilm eradication activity (40%) when compared to a marketed cream (20%).


Subject(s)
Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Mupirocin/pharmacology , Oils, Volatile/pharmacology , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects , Drug Resistance, Bacterial/drug effects , Eucalyptus Oil/pharmacology , Eugenol/pharmacology , Humans , Microbial Sensitivity Tests , Skin Cream/chemistry , Skin Cream/pharmacology
11.
J Drugs Dermatol ; 19(10): s4-s7, 2020 Oct 01.
Article in English | MEDLINE | ID: mdl-33026768

ABSTRACT

Colloidal oatmeal has a long-standing history in the treatment of dermatologic disease. It is composed of various phytochemicals, which contribute to its wide-ranging function and clinical use. It has various mechanisms of action including direct anti-inflammatory, anti-pruritic, anti-oxidant, anti-fungal, pre-biotic, barrier repair properties, and beneficial effects on skin pH. These have been shown to be of particular benefit in the treatment of atopic dermatitis. In Part 1 of this two-part series, we will explore the history of colloidal oatmeal, basic science, mechanism of action, and clinical efficacy in the treatment of atopic dermatitis. J Drugs Dermatol. 2020;19:10(Suppl):s4-7.


Subject(s)
Avena/chemistry , Dermatitis, Atopic/therapy , Dermatologic Agents/pharmacology , Plant Extracts/pharmacology , Administration, Topical , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Antioxidants/pharmacology , Antioxidants/therapeutic use , Baths/methods , Colloids , Cosmeceuticals/pharmacology , Cosmeceuticals/therapeutic use , Dermatologic Agents/therapeutic use , Dermatology/history , Dermatology/methods , Drug Approval , History, 20th Century , History, Ancient , Humans , Nonprescription Drugs/pharmacology , Nonprescription Drugs/therapeutic use , Plant Extracts/therapeutic use , Skin Cream/pharmacology , Skin Cream/therapeutic use , Treatment Outcome
12.
J Toxicol Environ Health A ; 83(11-12): 423-437, 2020 06 17.
Article in English | MEDLINE | ID: mdl-32546107

ABSTRACT

The aim of this study was to determine the effects of anti-wrinkle and skin-whitening of fermented black ginseng (FBG) in human subjects and to examine underlying biochemical mechanisms of action. A clinical study was performed to evaluate efficacy and safety using a 1% FBG cream formulation. Twenty-three subjects were recruited and instructed to apply control or FBG creams each on half of their face twice daily for 8 weeks. After 8 weeks FBG cream significantly reduced appearance of eye wrinkles compared to prior to exposure and control cream. Skin color was significantly brightened using FBG cream in comparison with control cream. To determine the mechanism of actions involved in anti-wrinkle and skin-whitening effects various concentrations of FBG were applied to human fibroblast CCD-986sk and mouse melanoma B16F1 cells. Collagen synthesis in CCD-986sk cells was improved significantly at 1, 3, 10, or 30 µg/ml of FBG. At 30 µg/ml, FBG significantly inhibited (73%) collagenase, and matrix metalloproteinase-1 (MMP-1) compared to control. Tyrosinase activity and DOPA (3,4-dihydroxy-L-phenylalanine) oxidation were significantly decreased at all tested concentrations. Melanin production in B16F1 cells was concentration-dependently reduced 15% to 60% by all concentrations of FBG. These results suggested that a 1% FBG cream exerted anti-wrinkle and skin-whitening effects.


Subject(s)
Panax/chemistry , Skin Aging/drug effects , Skin Pigmentation/drug effects , Animals , Cell Line , Cell Survival/drug effects , Collagen/biosynthesis , Dihydroxyphenylalanine/metabolism , Fermentation , Humans , Matrix Metalloproteinase Inhibitors/pharmacology , Melanins/biosynthesis , Mice , Monophenol Monooxygenase/antagonists & inhibitors , Monophenol Monooxygenase/metabolism , Oxidation-Reduction/drug effects , Plant Extracts/chemistry , Plant Extracts/pharmacology , Skin Cream/chemistry , Skin Cream/pharmacology
13.
Sci Rep ; 10(1): 6316, 2020 04 14.
Article in English | MEDLINE | ID: mdl-32286433

ABSTRACT

Skin health is vital for a healthy body. Herbal remedies have long been used for skin care, and their global use has tremendously increased over the past three decades. Although cellulite is seen as a normal condition by the medical community, it is considered a serious cosmetic concern for most affected women. Many topical anti-cellulite creams are available on the market, but unfortunately, their efficacy has not been proven scientifically. Microneedles (MNs) represent a new approach to enhance the permeation of loaded medication through the skin. In this study, the anti-cellulite effects of Vitex agnus-castus and Tamarindus indica extracts were compared using safe and effective polymeric MNs. This delivery system offers a painless alternative to the combined treatment strategy of microneedling devices and anti-cellulite products. The selected standardized extracts were evaluated for their mineral, phenolic and flavonoid contents, which are correlated to a promising antioxidant effect, as demonstrated by an in vitro radical scavenging activity assay. 3D-printing techniques were chosen for fabrication of a micromold, which is inexpensive for mass production. To ensure that MNs were sufficiently strong to perforate the skin without breaking, axial failure force was measured using a micro-mechanical test machine. The anticellulite effects of MNs were assessed using an in vivo diet-induced obesity guinea pig model. Skin properties, histopathology and inflammatory markers were examined. MNs loaded with plant extracts were statistically comparable in normalizing the oxidative state and reducing inflammation, while myeloperoxidase levels were more significantly reduced by T. indica than by V. agnus-castus. This novel delivery system opens the door for new transdermal strategies for cellulite management.


Subject(s)
Cellulite/drug therapy , Drug Delivery Systems/instrumentation , Obesity/complications , Plant Extracts/pharmacology , Skin Cream/pharmacology , Administration, Cutaneous , Animals , Cellulite/etiology , Disease Models, Animal , Female , Guinea Pigs , High Fructose Corn Syrup/administration & dosage , High Fructose Corn Syrup/adverse effects , Humans , Needles , Plant Extracts/therapeutic use , Polymers , Printing, Three-Dimensional , Skin/drug effects , Skin Cream/therapeutic use , Tamarindus/chemistry , Vitex/chemistry
14.
Carbohydr Polym ; 233: 115854, 2020 Apr 01.
Article in English | MEDLINE | ID: mdl-32059905

ABSTRACT

Prosopis juliflora is an invasive plant distributed throughout the world and presents metabolites of interest for cosmetology. The aim of this work was to develop a new polysaccharide-based ingredient from P. juliflora and analyze its application in a solid core formulation that upon contact with water instantly forms a gel to improve moisturizing and anti-aging skin properties. Purified extracts by gel chromatography were characterized by NMR and LC-DAD-MS-MS. The in vitro and in vivo safety, antioxidant activity, formulation development and clinical evaluation were performed. The extract was characterized as containing an α-glucan and phenolics. It was non-cytotoxic, non-phototoxic and no skin reactions were observed in vivo. Antioxidant activity were present through different mechanisms. Clinical evaluation reinforced the potential of P. juliflora in skin hydration and microrelief improvement. This innovative form proved to be a prototype of a new product and the first study of an α-glucan as a cosmetic ingredient.


Subject(s)
Antioxidants/pharmacology , Gels/pharmacology , Plant Extracts/pharmacology , Prosopis/chemistry , Skin Cream/pharmacology , Adult , Aged , Animals , Antioxidants/chemistry , Antioxidants/isolation & purification , Antioxidants/toxicity , BALB 3T3 Cells , Female , Flavonoids/chemistry , Flavonoids/isolation & purification , Flavonoids/pharmacology , Flavonoids/toxicity , Fruit/chemistry , Gels/chemistry , Gels/isolation & purification , Gels/toxicity , Glucans/chemistry , Glucans/isolation & purification , Glucans/pharmacology , Glucans/toxicity , Humans , Male , Mice , Middle Aged , Phenols/chemistry , Phenols/isolation & purification , Phenols/pharmacology , Phenols/toxicity , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/toxicity , Skin/drug effects , Skin Cream/chemistry , Young Adult
15.
Pharm Biol ; 57(1): 392-402, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31188689

ABSTRACT

Context: Citrus unshiu Markovich (Rutaceae) peel is known to contain high concentrations of flavonoids and exerts pharmacological effects on antioxidant, anti-inflammation, allergies, diabetes and viral infections. Objective: Very little is known about potential activity of fermented dried Citrus unshiu peel extracts (FCU) using Bacillus subtilis, as well as its mechanism of action. We investigated the effects of FCU on the anti-inflammatory activities in murine macrophages and moisturizing effects in human keratinocytes. Materials and methods: We isolated the Bacillus subtilis from Cheonggukjang and FCU using these Bacillus subtilis to prepare samples. The cells were pre-treated with various extracts for 2 h and then induced with LPS for 22 h. We determined the NO assay, TNF-α, IL-6 and PGE2 in RAW 264.7 ells. The expression of SPT and Filaggrin by FCU treatment was measured in HaCaT cells. Result: We found that two types of FCU highly suppressed LPS-induced nitric oxide (NO) without exerting cytotoxic effects on RAW 264.7 cells (21.9 and 15.4% reduction). FCU inhibited the expression of LPS-induced iNOS and COX-2 proteins and their mRNAs in a concentration-dependent manner. TNF-α (59 and 30.9% reduction), IL-6 (39.1 and 65.6% reduction), and PGE2 secretion (78.6 and 82.5% reduction) were suppressed by FCU in LPS-stimulated macrophages. Furthermore, FCU can induce the production of hyaluronic acid (38 and 38.9% induction) and expression of Filaggrin and SPT in HaCaT keratinocyte cells. Discussion and conclusion: FCU potentially inhibits inflammation, improves skin moisturizing efficacy, and it may be a therapeutic candidate for the treatment of inflammation and dry skin.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Citrus/chemistry , Keratinocytes/drug effects , Macrophages/drug effects , Plant Extracts/pharmacology , Animals , Bacillus subtilis/metabolism , Cell Line , Citrus/metabolism , Citrus/microbiology , Cyclooxygenase 2/metabolism , Dinoprostone/metabolism , Filaggrin Proteins , Humans , Immunologic Factors/pharmacology , Keratinocytes/metabolism , Lipopolysaccharides/pharmacology , Macrophage Activation/drug effects , Mice , Nitric Oxide Synthase Type II/metabolism , RAW 264.7 Cells , Skin Cream/pharmacology
16.
An Acad Bras Cienc ; 91(1): e20180171, 2019.
Article in English | MEDLINE | ID: mdl-30994761

ABSTRACT

Avicennia schaueriana is found in Brazilian mangrove coast. The cytotoxicity in vitro of the Aqueous Extract of Leaves of Avicennia schaueriana (AELAs) and the healing activity of the plant in cream on mice skin wounds were evaluated in this study. The cytotoxic evaluation was performed on Vero cells. The healing activity was evaluated on mice treated during 5, 10 and 15 days with cream at 5%, solution of sodium chloride at 0.9% and dexpanthenol in cream at 5%. The extract did not show cytotoxicity, but showed mitogenic activity (100µg/ml). In morphometric analysis, the percentage of wound contraction after 10 days was higher in dexpanthenol group (93.41%). In 15 days, the lowest percentage of contraction was observed in the dexpanthenol group (94.41%) and the highest in the AELAs cream group (98.50%). In histomorphometry the dexpanthenol showed the lowest length of re-epithelialization in 10 days. In 15 days, the AELAs cream group showed 100% of re-epithelialization. The number of fibroblasts found in AELAs cream group was higher than the saline solution in 10 days. In 15 days, AELAs cream group maintained a higher amount of fibroblasts when compared to the others. A. schaueriana did not show cytotoxicity. Furthermore, topical application of AELAs cream decreased the wound area, stimulated the re-epithelialization and increased the number of fibroblasts. The species A. schaueriana could become a topical treatment in tissue repair process.


Subject(s)
Avicennia/chemistry , Plant Extracts/pharmacology , Skin Cream/pharmacology , Wound Healing/drug effects , Administration, Cutaneous , Animals , Cells, Cultured , Chlorocebus aethiops , Female , Mice , Pantothenic Acid/analogs & derivatives , Pantothenic Acid/pharmacology , Plant Leaves/chemistry , Reproducibility of Results , Skin/pathology , Time Factors , Treatment Outcome , Vero Cells
17.
J Ethnopharmacol ; 238: 111828, 2019 Jun 28.
Article in English | MEDLINE | ID: mdl-30910580

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Curcuma mangga Valeton & Van Zijp. (Zingiberaceae family) contains curcuminoids and diterpenes which have anti-inflammatory effect. In traditional use, the elixir of this plant has been used to detoxify the poisonous plants, treatment of gastric ulcer, chest pain, fever, skin disease and womb healing. This plant has also been reported for anti-inflammation in carrageenan-induced rat paw edema. AIM OF THE STUDY: This study is aimed to evaluate the anti-inflammatory and wound healing effects of cream containing C. mangga in the formulation as well as physical and chemical stabilities. MATERIALS AND METHODS: Three cream base formulas were evaluated for color, smell, pH values, viscosity and separation. The most stable cream base was chosen to mix with 2-10% of C. mangga extract. After that, the physical, chemical and biological properties of C. mangga cream before and after heating-cooling were evaluated. RESULTS: The results showed that C. mangga cream exhibited good consistency, a pH range of acid value (5.0-6.0) and the cream was stable. Cream containing 10% w/w C. mangga inhibited inflammation before and after accelerating conditions with IC50 values of 34.1 and 37.9 µg/ml which were better than 5% (IC50 = 42.9, 44.7 µg/ml) and 2% (IC50 = 49.1, 49.6 µg/ml), respectively. In addition, the anti-inflammatory effect of cream containing C. mangga was found to be better than diclofenac gel (IC50 = 54.3 µg/ml). Cream containing C. mangga before and after heating-cooling test at 1 and 3 µg/ml enhanced HDF viability of over 100%, while cream containing 5% w/w C. mangga before and after heating-cooling test enhanced migration of HDF cells at 36 h up to 75-80%. The curcuminoids which are curcumin, demethoxycurcumin and bisdemethoxycurcumin showed good chemical stability after heating-cooling test by using HPLC with the relative peak area % at 10:75:15, respectively. CONCLUSION: This study concluded that the development of cream containing C. mangga could reduce inflammation and heal the wound.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Curcuma , Plant Extracts/pharmacology , Skin Cream/pharmacology , Animals , Anti-Inflammatory Agents/chemistry , Cell Movement/drug effects , Cell Proliferation/drug effects , Drug Stability , Mice , Nitric Oxide/metabolism , Plant Extracts/chemistry , RAW 264.7 Cells , Skin Cream/chemistry , Wound Healing/drug effects
18.
J Cosmet Dermatol ; 18(2): 628-637, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30146775

ABSTRACT

BACKGROUND: Green formulations with herbal oils and natural nonionic emulsifiers project several advantages, like favorable viscosity profiles, for use as topical applicants. Their inherent constituents also protect the skin against free radical damage and lipid peroxidation. They may hence serve as alternatives for synthetic chemical-based formulations. OBJECTIVE: Formulation and characterization of Helianthus annuus-alkyl polyglucoside cream for topical application has been attempted. Its inherent sun protection factor has been measured and compared with a similar commercial formulation. It is well known that the internal network of liquid crystals of such emulsifiers can store depot water to maintain moisturization for long time, thus bestowing beneficial dermatological effects. METHODS: Physicochemical characterization of the oil was done. The formulation process for the cream was optimized for reduced particle size with respect to ultrasonication conditions. It was characterized extensively; its inherent sun protection factor was measured and compared with a similar commercial cream. RESULTS: The cream was smooth, creamy, and showed non-Newtonian thixotropic behavior and good shear-thinning features with an SPF of 6.3 that compared favorably with a similar commercial cream. CONCLUSIONS: The cream may serve as a good topical applicant and also help in skin hydration due to the inherent nature of the emulsifier. It may protect against UV radiations due to the antioxidant and anti-inflammatory nature of the natural oil constituents. It may be used as a low-SPF formulation.


Subject(s)
Helianthus/chemistry , Plant Oils/chemistry , Skin Cream/chemistry , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Antioxidants/chemistry , Antioxidants/pharmacology , Bacteria/drug effects , Bacteria/isolation & purification , Emollients/chemistry , Emollients/pharmacology , Emulsifying Agents/chemistry , Emulsifying Agents/pharmacology , Emulsions , Healthy Volunteers , Humans , Microbial Sensitivity Tests , Plant Oils/pharmacology , Skin/microbiology , Skin Cream/pharmacology , Sun Protection Factor , Viscosity
19.
Biomed Res ; 39(4): 215-222, 2018.
Article in English | MEDLINE | ID: mdl-30101841

ABSTRACT

Previous studies have shown that dissolved substances in some natural hot springs have analgesic/anti-nociceptive and anti-inflammatory actions. However, the mechanisms underlying how such dissolved substances exert these actions are not fully understood. In the present study on mice, we examined the analgesic/anti-nociceptive and anti-inflammatory properties of a mineral cream containing natural hot spring ingredients. The anti-nociceptive effects of the mineral cream were assessed by using the von Frey test. Application of the mineral cream to the hind paw of mice produced a significant anti-nociceptive effect compared to control. The anti-nociceptive effects of the mineral cream were also assessed following the injection of complete Freund's adjuvant (CFA) into the hind paws of mice after pre-treatment for one or four weeks with the mineral cream. Histological experiments with light microscopy showed that the mineral cream did not reduce inflammation caused by the CFA treatment. In addition, the mineral cream did not inhibit oxidative stress as evidenced by increased levels of oxidative metabolites (d-ROMs) and biological anti-oxidant potential (BAP). These results suggest that the mineral cream does not exert a protective effect against inflammation, and that the constituents of the mineral cream may produce their anti-nociceptive effects transdermally via different mechanisms including the nervous system.


Subject(s)
Analgesics/pharmacology , Balneology , Minerals/pharmacology , Skin Cream/pharmacology , Analgesics/pharmacokinetics , Animals , Male , Mice , Mice, Inbred ICR , Minerals/pharmacokinetics , Skin Cream/pharmacokinetics
20.
J Dermatol Sci ; 89(2): 127-135, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29137840

ABSTRACT

BACKGROUND: Resolvin D1 (RvD1), a pro-resolution lipid mediator derived from docosahexaenoic acid (DHA), has been described to promote several kinds of inflammatory resolution. However, the effects and anti-inflammatory mechanisms of RvD1 on psoriasis have not been previously reported. OBJECTIVE: The present study aimed to determine the protective effects and the underlying mechanisms of RvD1 on imiquimod (IMQ)-induced psoriasiform dermatitis. METHODS: Mice were topically treated with IMQ to develop psoriasiform dermatitis on their shaved back, pretreated intraperitoneally (i.p.) with or without RvD1 or tert-butoxycarbonyl Met-Leu-Phe peptide (Boc), a lipoxin A4 (ALX) receptor antagonist. The severity was monitored and graded using a modified human scoring system, the Psoriasis Area and Severity Index (PASI), histopathology, and the signature cytokines of psoriasis (IL-23, IL-17, IL-22 and TNF-α). The mRNA and protein levels of inflammatory cytokines were quantified by quantitative real-time PCR (QRT-PCR) and ELISA. The expressions of signaling proteins MAPKs and NF-κB p65 were analyzed using western blotting. Electrophoretic mobility shift assay (EMSA) was used to check NF-κB p65 DNA binding activity. RESULTS: Our study showed that RvD1 alleviated IMQ-induced psoriasiform dermatitis and improved skin pathological changes. RvD1 markedly inhibited IMQ-induced activation of ERK1/2, p38, JNK (c-Jun N-terminal protein kinase, a subfamily of MAPKs), and NF-κB. Furthermore, pretreatment with Boc, would not exacerbate skin inflammation of IMQ-induced mice, but significantly reversed the beneficial effects of RvD1 on IMQ-induced psoriasiform inflammation. CONCLUSION: RvD1 can obviously improve skin inflammation in IMQ-induced mice psoriasiform dermatitis. The protective mechanisms might be related to its selective reaction with lipoxin A4 receptor/Formyl-peptide receptor 2 (ALX/FPR2), by downregulating relevant cytokines of the IL-23/IL-17 axis expression, the inhibition of MAPKs and NF-κB signaling transduction pathways. Thus, these results show that RvD1 could be a possible candidate for psoriasis therapy.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Dermatitis/drug therapy , Docosahexaenoic Acids/therapeutic use , Psoriasis/drug therapy , Signal Transduction/drug effects , Administration, Cutaneous , Aminoquinolines/immunology , Animals , Anti-Inflammatory Agents/pharmacology , Dermatitis/immunology , Dermatitis/pathology , Disease Models, Animal , Docosahexaenoic Acids/pharmacology , Drug Evaluation, Preclinical , Humans , Imiquimod , Male , Mice , Mice, Inbred BALB C , Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/metabolism , Psoriasis/immunology , Psoriasis/pathology , Severity of Illness Index , Skin/drug effects , Skin/metabolism , Skin/pathology , Skin Cream/pharmacology , Skin Cream/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL